Cargando…
Alendronate slows down aortic stenosis progression in osteoporotic patients: An observational prospective study
BACKGROUND: Aortic stenosis (AS) is the most common primary valvular disease. Currently, there is no pharmacological approach for the medical management of AS. We investigated the effect of osteoporosis therapy with alendronate on hemodynamic progression in patients concurrently affected by AS and o...
Autores principales: | Alishiri, Gholamhossein, Heshmat-Ghahdarijani, Kiyan, Hashemi, Mohammad, Zavar, Reihaneh, Farahani, Maryam Moshkani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554420/ https://www.ncbi.nlm.nih.gov/pubmed/33088302 http://dx.doi.org/10.4103/jrms.JRMS_408_20 |
Ejemplares similares
-
The frequency of anti-phospholipid antibody syndrome in patients with premature coronary artery disease
por: Alishiri, Gholamhossein, et al.
Publicado: (2018) -
Evaluation the effect of low-dose aspirin on endothelial dysfunction in preeclamptic patients
por: Hashemi, Mohammad, et al.
Publicado: (2016) -
Co-infection between the severe acute respiratory syndrome coronavirus 2 and the influenza Type B in Isfahan, Iran
por: Heshmat-Ghahdarijani, Kiyan, et al.
Publicado: (2021) -
Evaluation of the effect of high-dose folic acid on endothelial dysfunction in pre-eclamptic patients: A randomized clinical trial
por: Hashemi, Mohammad, et al.
Publicado: (2016) -
Alterations of Lipid Profile in COVID-19: A Narrative Review
por: Rezaei, Abbas, et al.
Publicado: (2022)